KSZ TDEM surveys - presentation on Vox Markets
Botswana, will participate in an investor webinar on
Tuesday May 18
5.30pm on Vox Markets.
Ben Turney, Executive Director of Kavango, will present the Company s latest results of exploration in the
Kalahari Suture Zone ( KSZ ).
As Kavango seeks to unlock the KSZ s significant potential to host large-scale metal sulphide deposits, the Company has deployed Time Domain Electromagnetic ( TDEM ) surveying technology to identify targets, for a drill campaign later this year.
Following the success of the first TDEM surveys, Kavango recently entered into a strategic partnership with Spectral Geophysics, a highly experienced and effective operator of TDEM powerful technology, to complete a more extensive programme.
KSZ TDEM Update and Warrant Exercise
Botswana, is pleased to announce an update on its
Kalahari Suture Zone ( KSZ ) project, receipt of
£59,500 in warrant exercises and completion of the strategic partnership with Spectral Geophysics ( Spectral ) (announced 20 April 2021).
KSZ Update
Further to the announcement on
20 April 2021, Spectral has completed a third Time Domain Electromagnetic ( TDEM ) survey in Target Area A ( Survey A3 ). This survey was designed to corroborate the existence of the large-scale conductive anomaly previously identified. Spectral also deployed an upgraded configuration of its equipment, which has proved to be successful.
TDEM surveys can be used to identify super electromagnetic ( EM ) conductors at depth, within highly complex geological environments such as the KSZ. Spectral Geophysics is a highly experienced and effective operator of TDEM technology currently being employed on the project.
(1)
TORONTO, ON / ACCESSWIRE / May 5, 2021 / Tartisan Nickel Corp. (CSE:TN)(OTC PINK:TTSRF)(FSE:A2D) ( Tartisan , or the Company ) is pleased to provide an update on the Kenbridge Nickel Project, Kenora Mining District, Ontario. The Company had contracted Crone Geophysics & Exploration Limited to perform a surface Time Domain Electromagnetic ( TDEM ) survey at Kenbridge North, 2.5km to the north of the Kenbridge Deposit, as well as borehole geophysics at the known Kenbridge Deposit. The Kenbridge North target is interpreted to represent similar rock types that host the Kenbridge Deposit.
Results of the surface TDEM survey at Kenbridge North shows a strong conductor known as KBN1 which appears to extend minimally over 400 meters with a similar strike direction as the Kenbridge Deposit. A second conductor, KBN2 was also identified on Kenbridge North, specifically on the northern portion of the grid. KBN2 requires further ground follow up in the upcoming exploration program.
GameSquare Esports Inc (CSE:GSQ) (FRA:29Q1), through its Gaming Community Network (GCN) division, has signed a sales partnership with Even Matchup Gaming (EMG). The company said EMG owns and operates major esports events, including Get On My Level, the largest fighting game tournament in Canada, and Let s Make Moves, the largest Super Smash Bros event in the New York area. “We see a lot of potential in helping EMG’s team maximize their sales pipeline,” said Justin Kenna, CEO of GameSquare, in a statement.
Mydecine Innovations Group Inc (NEO:MYCO) (OTCMKTS:MYCOF) (FRA:0NFA) has announced a partnership with LeadGen Labs, a custom synthesis and contract research organization, to support Mydecine’s novel psychedelic drug development efforts and increase the number of novel molecules the company can synthesize concurrently. Following the announcement of the company’s four initial drug candidates, the Denver-based company said it and LeadGen Labs will work to synthesize no
GameSquare Esports Inc (CSE:GSQ) (FRA:29Q1), through its Gaming Community Network (GCN) division, has signed a sales partnership with Even Matchup Gaming (EMG). The company said EMG owns and operates major esports events, including Get On My Level, the largest fighting game tournament in Canada, and Let s Make Moves, the largest Super Smash Bros event in the New York area. “We see a lot of potential in helping EMG’s team maximize their sales pipeline,” said Justin Kenna, CEO of GameSquare, in a statement.
Mydecine Innovations Group Inc (NEO:MYCO) (OTCMKTS:MYCOF) (FRA:0NFA) has announced a partnership with LeadGen Labs, a custom synthesis and contract research organization, to support Mydecine’s novel psychedelic drug development efforts and increase the number of novel molecules the company can synthesize concurrently. Following the announcement of the company’s four initial drug candidates, the Denver-based company said it and LeadGen Labs will work to synthesize no